Cigna PBM Express Scripts to Remove Humira From Many Formularies
CVS Health Corporation's (NYSE:CVS) Has Performed Well But Fundamentals Look Varied: Is There A Clear Direction For The Stock?
Is the rebound fading? Goldman Sachs: Hedge funds are selling stocks at the fastest pace in more than two years.
In August, 'smart money' is selling global equities at the fastest pace since March 2022, with the most net selling in North America. Hedge funds are skeptical of the sustainability of the stock market rebound, and geopolitical concerns continue to be worrying. The 'fly' of the economic situation may soon hit the glass windshield.
Inc. Magazine Ranks Banner|Aetna Among America's Fastest-growing Companies
Target Closed Crime-prone Stores and It Appears to Have Paid Off. Why That May Result in Future 'Retail Deserts.'
As Theft Increases, Store Closures and 'Retail Deserts' Could Be the New Consumer Reality
CVS Pharmacy Introduces Colleague-designed Journals
CVS Health Insider Lowered Holding By 40% During Last Year
Investing in Healthcare: CVS Has Lost 'Competitive Advantage'
Decoding CVS Health's Options Activity: What's the Big Picture?
Kooth Launches Digital Well-being Partnership With Aetna
Weaker Earnings Report Dragged CVS Health Corporation (CVS)
Leerink Partners Maintains CVS Health(CVS.US) With Hold Rating, Maintains Target Price $60
Analysts Have Conflicting Sentiments on These Healthcare Companies: CVS Health (CVS), Pharvaris (PHVS) and United Therapeutics (UTHR)
10 Health Care Stocks Whale Activity In Today's Session
Express News | Cantor Fitzgerald Reiterates Neutral on CVS Health, Maintains $62 Price Target
CVS Health Analyst Ratings
Pharmacy Chains Like CVS Health, Walgreens Boots Alliance Confront Shifting Consumer Habits And Profit Pressures
Argus Adjusts Price Target on CVS Health to $75 From $80, Maintains Buy Rating
CVS Health Corporation (NYSE:CVS) Is a Favorite Amongst Institutional Investors Who Own 83%